TROY EDWARD WILSON

CIK 1589597 · President and CEO · last filed 2026-03-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.00M

Companies

5

Total Filings

67

Lifetime Open-Market Net

-$24.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KURA President and CEO 714,650 $9.05 $6.47M -$18.19M 30 2026-03-25
Avidity Biosciences, Inc. (RNAM) Delisted Director 0 $0 1 2026-02-27
RNA Director 97,636 $12.37 $1.21M -$5.75M 10 2025-09-09
PBYI Director 43,950 $7.33 $322.2K -$836.0K 20 2025-06-17
Zosano Pharma Corp (ZSAN) Delisted Director 3,000 $0.56 $1.7K $0 5 2019-07-18

Recent Filings · Page 6 of 7

67 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-01 Zosano Pharma Corp (ZSAN) Delisted Grant (A) $0 EDGAR
2018-03-02 Zosano Pharma Corp (ZSAN) Delisted Grant (A) $0 EDGAR
2018-01-26 KURA Grant (A) $0 EDGAR
2017-08-23 KURA Exer (M) +27,985 $134.3K EDGAR
2017-06-14 PBYI Grant (A) $0 EDGAR
2017-04-24 KURA Exer (M) +5,000 $24.0K EDGAR
2017-01-25 KURA Grant (A) $0 EDGAR
2016-11-16 PBYI Grant (A) $0 EDGAR
2016-11-04 Zosano Pharma Corp (ZSAN) Delisted Grant (A) $0 EDGAR
2016-02-02 KURA Grant (A) $0 EDGAR
Showing 5160 of 67
Page 6 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.